HDAC9 and glioma: HDAC and miRNAs have been shown to interact with each other (reviewed in [170]), combination of selective HDAC inhibitors and new miRNA silencing techniques (reviewed in [171,172]) may form a new perspective in epigenetics-based therapies targeting TMMs in gliomas.